Member Info for Rocket79

Funding now sorted nothing holding back share price now.

Good result, long extension and cash of 145 mil. Looking more confident for future of Amigo.

I'm a holder but expect a dip back below 60p as the news is good for the market overall but 4d have a different approach. This will rerate once 4d produces news of it's own. I'm a holder but not adding as this has risen to quickly today. I hope I'm wrong but I will add again at 50p if it gets there.

Looking like a good entry point here. Looking like this will turn very shortly as drop over done imo. 30p first stop.

Gone into auction MMs desperate for stock. My advice Hold and let them squirm and watch sp rocket. My target 25p

Bitcoin and other cryptocurrencies are having a mega quarter. Watch this rerate once investors realise we mine bitcoin and zcash.

Argo still under the radar of investors. Buying all I can before this rerates. Good luck all

I think anyone buying now is getting in very cheaply. Not sure how long we will stay this undervalued for. My target price is above 25p with bitcoin trading at 15k

Bitcoin over 11k these will rerate . As has been pointed out there is a massive valuation gap compared to peers. Buy at these ridiculously cheap price imo

Yeah management happy with Bitcoin price also. This is going to turn into a cash cow imo. Dividends will be coming in the near future imo

Bitcoin also doing well. These will hit 10p next week and easily above 20p if bitcoin hits 15k imo

Tree shake dont give away your shares cheaply. Buy on any dips.

If bitcoin gets near 20k this will be over 20p easy

500p price target for end of 2020. These are high risk but the risk/reward is currently in our favour at current price imo.

Sold here and bought 4d pharma DDDD logical place for profits and another 200% rise. Good luck all

Level 2 longer strongest I have seen it in weeks. First stop 52p breaks that then 100p good luck all. Strong Buy

Looking at those valuations we would be ahead of all of those companies. The sp should be trading around 500p + imo. No wonder they are looking at a Nasdaq listings where our valuation would truly show.

Looking at those valuations we would be ahead of all of those companies. The sp should be trading around 500p + imo. No wonder they are looking at a Nasdaq listings where our valuation would truly show.

Great interview thanks for posting. Confirmed seller now cleared. Watch this rerate over next few weeks as undervalued at this price and nothing now holding it back.

Surely not long now before a some further news on licensing deals ..

www.proactiveinvestors.co.uk/companies/amp/news/921377

Bargain territory?

A catalyst for a more realistic valuation might be a partnership of some description, adding to 4D’s research collaboration with MSD Merck & Co in the vaccines space.

A licensing deal in the oncology space would seem an ideal place to start, though Peyton believes MRx0518 has the potential to work with other immune checkpoint inhibitors, not just Keytruda.

“Of course, MSD is a ready-made partner and we like working with them, but there are others out there,” he adds.

“We have multiple conversations ongoing around IBS and we’ve done a lot of pre-clinical work in autoimmune and oncology too.

“We have conversations in all those areas, and conversations about the platform itself.”

Let’s hope those conversations help crystalise value